IMPLICATIONS OF ANTIHYPERTENSIVE THERAPY ON SODIUM-BALANCE AND SODIUM AND WATER-RETENTION

被引：17

作者：

LEDINGHAM, JGG

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 12卷

关键词：

D O I：

10.1111/j.1365-2125.1981.tb00290.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S15 / S21

页数：7

共 65 条

[1]

ABDELRAZZAK M, 1977, ARCH INT PHARMACOD T, V229, P227

[2]

ATKINSON AB, 1979, LANCET, V2, P836

[3] INTERRUPTION OF THE RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS BY CAPTOPRIL INDUCES SUSTAINED REDUCTION IN ALDOSTERONE SECRETION, POTASSIUM RETENTION AND NATRIURESIS [J].

ATLAS, SA ;

CASE, DB ;

SEALEY, JE ;

LARAGH, JH ;

MCKINSTRY, DN .

HYPERTENSION, 1979, 1 (03) :274-280

[4]

BAYLISS RIS, 1962, LANCET, V1, P763

[5]

BEILIN LJ, 1972, LANCET, V1, P979

[6] EFFECT OF RENAL SYMPATHETIC-NERVE STIMULATION ON PROXIMAL WATER AND SODIUM-REABSORPTION [J].

BELLOREUSS, E ;

TREVINO, DL ;

GOTTSCHALK, CW .

JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (04) :1104-1107

[7] BLOOD-PRESSURE CHANGES PRODUCED BY KIDNEY CROSS-TRANSPLANTATION BETWEEN SPONTANEOUSLY HYPERTENSIVE RATS AND NORMOTENSIVE RATS [J].

BIANCHI, G ;

FOX, U ;

DIFRANCE.GF ;

GIOVANETTI, AM ;

PAGETTI, D .

CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1974, 47 (05) :435-448

[8]

BIRKENHAGER WH, 1979, ROYAL SOC MED INT C, V26, P163

[9]

BORST JGG, 1963, LANCET, V1, P677

[10] CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J].

BRAVO, EL ;

TARAZI, RC .

HYPERTENSION, 1979, 1 (01) :39-46

← 1 2 3 4 5 6 7 →